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ABSTRACT
Background: In young children with wheezing or bronchiolitis, especially with respiratory syncitial virus, blood
eosinophilia and a high eosinophil cationic protein level in nasal secretions predicts subsequent wheezing in
later childhood. However, whether eosinophil activation results from virus-induced inflammation or local eosino-
philia per se precedes the onset of wheezing remains unknown. In the present study, we examined the asso-
ciation between the presence of nasal eosinophils during respiratory tract infection (RTI) and subsequent
wheezing in young children.
Methods: A total of 35 young children less than 3 years of age who visited our outpatient clinic with rhinorrhea
between April and July 2004 were enrolled in this prospective cohort study. Subjects who were given diagno-
ses of allergic rhinitis were excluded. In all the subjects, the presence of eosinophils in nasal secretions was
determined. The subjects were followed, and the cumulative incidences of wheezing during the subsequent 2-
and 12-month periods were examined.
Results: According to a logistic regression analysis adjusted for age, sex, family history, allergies, and wheez-
ing at entry, young children with nasal eosinophil infiltration during acute RTI had a significantly higher risk of
wheezing during the subsequent 2 months, compared with those without nasal eosinophil infiltration (adjusted
odds ratio, 27.618, p = 0.016).
Conclusions: Our findings not only suggest that nasal eosinophil testing may serve as a convenient clinical
marker for identifying young children at risk for subsequent wheezing, but also shed new light on the role of
eosinophils in the onset of wheezing in young children.
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INTRODUCTION
Wheezing is a very common symptom of lower respi-
ratory tract infection (RTI) in infants; 34% of infants
experience at least one wheezing episode by the age
of 3 years, while 49% experience at least one episode
by the age of 6.1 The small absolute size of the air-
ways, airway edema, mucus hypersecretions, im-
paired humoral protections and immature immune
responses render infants and young children particu-
larly susceptible to airway obstruction and can cause
wheezing.2,3 The majority of infants with wheezing
have transient conditions associated with diminished
airway function at birth and do not have increased
risks of asthma or allergies later in life. In a substan-
tial minority of infants, however, wheezing episodes
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are probably related to a predisposition to asthma.1
Stein et al. have reported three different wheezing
phenotypes in childhood: “transient early wheezing”,
“non-atopic wheezing” and “IgE-associated wheeze
asthma”.4 They also showed that only one third of
wheezing infants exhibit persistent wheezing at any
age with methacholine hyperresponsiveness, peak
flow variability, and markers of atopy.
Bronchiolitis is one of the most severe types of
lower RTI in infancy and is the most common disease
requiring the hospitalization of infants among devel-
oped countries.5 Approximately 70% of viral bron-
chiolitis is caused by respiratory syncytial virus
(RSV) infection.6 However, RSV is a common patho-
gen for RTIs among all age groups, especially during
the winter season, and the symptoms of most patients
with RSV infection are restricted to within the upper
airways.7,8 Thus, additional factors, such as Th2-
deviated immune responses9 or allergic predisposi-
tions,10 are thought to play some roles in the onset of
RSV-induced lower RTI, including bronchiolitis. RSV
bronchiolitis in early childhood is an important risk
factor for the subsequent development of asthma.11,12
In infants with wheezing or bronchiolitis, it is ex-
tremely important to investigate useful clinical mark-
ers capable of distinguishing early asthma patients
from transient early wheezers to initiate possible
early intervention or primary prevention strategies.
For this purpose, a clinical index for defining the risk
of asthma in young children with recurrent wheezing
has been investigated.13 Along with a familial history
of asthma and a past history of atopic dermatitis, pe-
ripheral blood eosinophilia has been reported to be a
valuable marker for predicting subsequent wheez-
ing.13 In addition, the serum eosinophil cationic pro-
tein (ECP) levels at the time of the first wheezing epi-
sode14 and the nasal ECP levels15,16 were also re-
ported to be strong predictors of subsequent wheez-
ing and asthma.
In infants with bronchiolitis, a number of investiga-
tors have reported similar findings-namely, that blood
eosinophilia17-19 and elevated serum ECP levels pre-
dict the onset of subsequent wheezing,20-23 even
though neutrophil activation is reportedly correlated
with disease severity.24,25 However, some controver-
sial observations have also been reported.22,26 Such
controversy may be due to differences between local
immune responses and peripheral blood testing.27-30
For example, in patients with abundant eosinophil ac-
cumulation in the lung during the acute phase of
bronchiolitis, the eosinophil ratio in the peripheral
blood may be relatively low. Therefore, markers of lo-
cal eosinophil activation should be expected; ECP22,31
or RANTES32 concentrations in nasal lavage fluid or
nasal discharge during bronchiolitis have also been
reported to be highly predictive of subsequent wheez-
ing.
These findings strongly suggest that local eosino-
philic inflammation during wheezing or bronchiolitis
is positively associated with subsequent wheezing in
young children with wheezing episodes or bronchioli-
tis. However, whether eosinophil activation results
from virus-induced inflammation or local eosinophilia
per se precedes the onset of wheezing remains un-
known. This point is of particular interest for deter-
mining the role of eosinophils in the formation of
wheezing in young children. In the present study, we
prospectively examined the association between the
presence of nasal eosinophils during RTI and subse-
quent wheezing in young children.
METHODS
SUBJECTS
A total of 35 young children (19 boys and 16 girls, age
6―33 months) who visited our outpatient clinic in Ko-
chi, Japan, between April and July, 2004, and whose
chief complaint was rhinorrhea were enrolled in this
prospective cohort study. None of the subjects had
experienced more than one wheezing episode prior
to enrollment. Subjects who had been given diagno-
ses of allergic rhinitis by a physician were excluded
from the study.
Informed consent was obtained from the parents of
all the participating subjects, and the study was ap-
proved by the Ethics Review Board of Kochi Medical
School.
METHODS
At the time of entry, the parents of the subjects an-
swered a questionnaire regarding the age, sex, and
the history of physician-diagnosed allergic diseases,
including atopic dermatitis, food allergy, asthma, al-
lergic conjunctivitis and urticaria, of both the subjects
and their parents.
Nasal secretions were sampled during the first visit
by swabbing the bilateral middle one-third inferior
turbinates with cotton swabs. The samples were
spread onto a slide glass, air-dried, fixed, and stained
with Wright-Giemsa solution (Wako Pure Chemical
Industries, Ltd., Osaka, Japan). The samples were
then evaluated for the presence or absence of eosino-
phils by examining 5 high power fields (HPFs) with a
light microscope (Olympus, Tokyo, Japan).
The subjects were further examined by the same
pediatrician 2 and 12 months after the first visit. The
cumulative incidences of wheezing during the follow-
up periods were then determined.
STATISTICS
A logistic regression model adjusted for age, sex,
family history, allergic diseases in the subjects,
wheezing at study entry, and eosinophils in the nasal
secretion was analyzed using STATA software (Stata-
Corp LP, College Station, TX, USA) and considered
to be significant when p < 0.05. The post-estimated
goodness of fit (Hosmer-Lemeshow) was confirmed
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Table 1 Descriptive characteristics of the subjects at study entry and the presence or absence of eosinophils in nasal secre-
tions
p value
Eosinophils in nasal secretionsTotal
Characteristics †
No (N＝19)Yes (N＝16)(N＝35)
0.407(6―33)15.0(6―32)18.2(6―33)16.5Age (months) ‡
0.371(47)9/10(63)10/6(54)19/16Sex (M/F) §
0.268(32)6/13(50)8/8(40)14/21Wheezing at study entry
(Y/N) §
0.640(42)8/11(50)8/8(46)16/19Family history §
Alergic diseases in the subject ¶
0.347(21)4/15(7)1/15(14)5/30Atopic dermatitis
0.415(26)5/14(13)2/14(20)7/28Food alergy
1.000(11)2/17(13)2/14(11)4/31Asthma
†Mean value or the number in the population, and the percentage or range.
‡Two-sample Wilcoxon rank-sum (Mann-Whitney) test.
§ χ2 test.
¶ Fisher's exact test.
Table 2 Laboratory findings for peripheral blood samples at study entry and the presence or absence of eosinophils in nasal 
secretions
p value ‡
Eosinophils in nasal secretions
Total
Laboratory findings † NoYes
(N＝10)(N＝11)(N＝21)
0.898667.6 (5―2100)  546.8 (5―2700)472.1 (5―2700)Total IgE (IU/mL)
0.9344.4 (0.7―10) 5.3 (0―32)4.9 (0―32)Percent of eosinophil (%)
0.933430.6 (48.3―1150)537.3 (0―3648)486.5 (0―3648)Number of eosinophils (/mm3)
†Mean value or the number in the population and the percentage or range are shown.
‡Two-sample Wilcoxon rank-sum (Mann-Whitney) test.
for all logistic regression analyses. The χ2 test,
Fisher’s exact test and Wilcoxon rank-sum (Mann-
Whitney) test were also performed using STATA soft-
ware.
RESULTS
All 35 subjects completed the 12-month study. The
descriptive characteristics of the subjects at entry are
shown in Table 1. Age, sex, presence of wheezing at
entry, family history of allergic diseases and allergic
diseases in the subject were not associated with the
presence or absence of eosinophils in the nasal secre-
tions at entry (Table 1). The total IgE level, periph-
eral blood eosinophil ratio, and the number of eosino-
phils also were not associated with the presence or
absence of eosinophils in the nasal secretions at entry
(Table 2). In addition, both the maternal and paternal
histories of any allergic diseases, particularly allergic
rhinitis or asthma, were not associated with the pres-
ence or absence of eosinophils in the nasal secretion
at entry (data not shown).
The age of infection has been reported to regulate
cytokine production and disease patterns later in
life.33 Sex and a family history of allergic diseases are
well-known to be associated with the risk of allergic
diseases during childhood.4 In addition, children with
wheezing episodes tend to wheeze more than those
without episodes.1 To evaluate the effects of these
confounding factors, a logistic regression model ad-
justed for age, sex, family history, allergic diseases in
the subject and presence or absence of wheezing at
entry was analyzed (Table 3). According to the logis-
tic regression analysis, young children with nasal
eosinophil infiltration during acute RTI had a signifi-
cantly higher risk of wheezing during the subsequent
2-month period than those without nasal eosinophil
infiltration (adjusted odds ratio (OR) 27.618; p =
0.016). The presence of wheezing at study entry was
also a strong risk factor for subsequent wheezing (ad-
justed OR, 20.324; p = 0.024), as expected.1
In contrast, nasal eosinophil infiltration during
acute RTI was not associated with the risk of wheez-
ing during the subsequent 12-month period (adjusted
OR, 4.099; p = 0.161; Table 4).
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Table 3 Efect of age, sex, alergic diseases in the subject, family history, eosinophils in nasal secretions and wheezing at 
study entry on the risk of wheezing during the subsequent 2 months
p value†Adjusted OR (95% CI)Crude OR (95% CI)(%)Wheezing positiveTotalVariable
0.4451.048 (0.929―1.181)1.012 (0.939―1.090)(43)1535Age
Sex
1.0001.000(37) 719Male
0.8241.240 (0.186―8.254)1.714 (0.443―6.629)(50) 816Female
Alergic diseases in the subjects
1.0001.000(48)1021No
0.3023.919 (0.293―52.414)1.000 (0.284―4.256)(50) 714Yes
Family history of alergic diseases
1.0001.000(53)1019No
0.2220.267 (0.032―2.218)0.409 (0.102―1.640)(31) 516Yes
Wheezing at study entry
1.0001.000(33) 721No
0.024＊20.342 (1.480―279.619)2.667 (0.661―10.751)(57) 814Yes
Eosinophils in nasal secretions
1.0001.000(37) 719No
0.016＊27.618 (1.859―410.201)1.714 (0.443―6.629)(50) 816Yes
†Adjusted for age, sex, family history, alergic diseases in the subject, eosinophils in nasal secretions and wheezing at study entry.
＊p＜0.05.
Table 4 Efect of age, sex, alergic diseases in the subject, family history, eosinophils in nasal secretions and wheezing at 
study entry on the risk of wheezing during the subsequent 12 months
p value†Adjusted OR (95% CI)Crude OR (95% CI)(%)Wheezing positiveTotalVariable
0.9771.0011.012 (0.939―1.090)(43)1535Age
Sex
1.0001.000(37) 719Male
0.1783.287 (0.582―18.571)1.714 (0.443―6.629)(50) 816Female
Alergic diseases in the subject
1.0001.000(33) 721No
0.0955.128 (0.751―35.020)2.667 (0.661―10.751)(57) 814Yes
Family history of alergic diseases
1.0001.000(53)1019No
0.1610.296 (0.060―1.458)0.409 (0.102―1.640)(31) 516Yes
Wheezing at study entry
1.0001.000(33) 721No
0.3042.488 (0.438―14.127)2.667 (0.661―10.751)(57) 814Yes
Eosinophils in nasal secretions
1.0001.000(37) 719No
0.1614.099 (0.577―29.500)1.714 (0.443―6.629)(50) 816Yes
†Adjusted for age, sex, family history, alergic diseases in the subject, eosinophils in nasal secretions, and wheezing at study entry.
DISCUSSION
In young children with wheezing and in young chil-
dren with bronchiolitis, especially as a result of RSV
infection, blood eosinophilia and nasal ECP predict
subsequent wheezing. To test whether eosinophil ac-
tivation is a result of virus-induced inflammation or lo-
cal eosinophilia per se precedes the formation of
wheezing, we prospectively examined the association
between the presence of nasal eosinophils during RTI
and subsequent wheezing in young children. As a re-
sult, we found that children with eosinophil infiltra-
tion in their nasal secretions during RTI were more
likely to experience episodes of wheezing during the
subsequent 2 months. The lack of association be-
tween the number of peripheral blood eosinophils
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and the presence of nasal eosinophils (Table 2) sug-
gests the presence of some specific mechanisms at-
tracting eosinophils to the nasal mucosa during RTI
in young children.
Nasal eosinophils probably do not play a direct role
in the lower airway. However, recent studies have
demonstrated that allergic inflammation in the upper
airway is closely related to allergic inflammation in
the lower airway; this phenomenon is now referred to
as “One Airway, One Disease”.34 In other words, pa-
tients with nasal eosinophil infiltration tend to have
eosinophil infiltration in their lungs as well.
Among the virus-induced chemokines that are pre-
sent in the lung,35 RANTES is known to recruit,36
prime and activate eosinophils in vitro.37 Eosinophil
activation, especially leukotriene production, may
participate in the formation of allergic inflammation
and may cause wheezing. As a matter of fact, the lev-
els of leukotrienes, but not of prostaglandin D2, are
elevated in the bronchoalveolar lavage fluid of young
children with persistent wheezing, suggesting that
eosinophil activation, but not mast cell activation,
plays critical roles in the formation of inflammatory
reactions in the lung, particularly in young children.38
In addition, anti-inflammatory therapy with oral corti-
costeroid39 or with leukotriene antagonists40 reduced
the incidence of subsequent wheezing in children
with bronchiolitis. However, a recent early interven-
tional study with intermittent inhaled corticosteroids
from infancy failed to alter the onset of asthma.41 Fur-
ther investigations are surely needed to determine
whether treatment with corticosteroids or leukot-
riene antagonists can modify the natural course of
asthma in young children.
Our findings strongly suggest that the detection of
nasal eosinophils during RTI may be a clinically use-
ful marker of the risk of subsequent wheezing. Young
children with nasal eosinophil infiltration during
acute RTI should receive early interventions; practi-
cally speaking, this means that the avoidance of irri-
tants, including passive smoke,7 and the avoidance of
the aeroallergen exposure to diminish allergic sensiti-
zation42 should be strongly recommended.
In a previous study, the effect of eosinophil activa-
tion during bronchiolitis on the increased risk of
asthma persisted until adulthood.27 In our study, how-
ever, nasal eosinophil infiltration during RTI showed
a positive association only with the near-term risk of
wheezing (2 months), but not with the long-term risk
of wheezing (12 months). This may reflect the fact
that eosinophils accumulating in the airway survive
only a short period of time and require an additional
supply from the peripheral blood to maintain the al-
lergic inflammatory reactions that cause recurrent
wheezing.
This study has some limitations. First, virus detec-
tion was not performed in any of the subjects, al-
though the study was performed during the non-RSV
season.8 Host immune responses against individual
viruses are not the same16,43,44; eosinophil-recruiting
chemokines are strongly produced and released from
bronchial epithelial cells after in vitro stimulation
with RSV.45,46 Eosinophils have been reported to be
activated by RSV-induced chemokines,37 by RSV di-
rectly,47 and by RSV-infected epithelial cells through
CD18-mediated interactions.48 Thus, whether the as-
sociation between nasal eosinophils and subsequent
wheezing is affected by different types of viruses
should be further examined. Second, the number of
eosinophils in the nasal secretions was only qualified,
but not quantified. Determining whether an associa-
tion exists between the number of infiltrating eosino-
phils and subsequent wheezing would be a point of
interest. Finally, 14 subjects exhibited wheezing at
study entry, even though the number of wheezing
episodes had been no more than one. In this context,
the subjects were not considered to have “upper res-
piratory tract infections”.15 However, the subject
population was typical of that visiting private outpa-
tient clinics; as mentioned earlier, wheezing is a very
common symptom in infancy and occurs in approxi-
mately one third of infants under 3 years of age.1 In
addition, our logistic regression model for analyzing
the effect of the presence of nasal eosinophils on sub-
sequent wheezing included an adjustment for the ef-
fect of wheezing at study entry.
Our findings strongly suggest that eosinophil acti-
vation precedes an allergic symptom, wheezing, in
subjects with RTI. Our findings were compatible with
our previous observation that eosinophilia in the cord
blood preceded the onset of infantile eczema.49 How-
ever, whether eosinophils play important roles in the
onset of allergic diseases or are just a marker of aller-
gic symptoms remains uncertain, even though
eosinophils certainly play critical roles in airway re-
modeling.50 In conclusion, the present findings not
only suggest that nasal eosinophil testing may serve
as a convenient clinical marker for identifying young
children at risk for subsequent wheezing, but also
shed new light on the role of eosinophils in the onset
of wheezing in young children.
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